Epah, J., Spohn, G., Preiß, K., Müller, M. M., Dörr, J., Bauer, R., . . . Schäfer, R. (2023). Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss. BMC Medicine, 21(1), 1. https://doi.org/10.1186/s12916-023-03059-3
Chicago Style (17th ed.) CitationEpah, Jeremy, et al. "Small Volume Bone Marrow Aspirates with High Progenitor Cell Concentrations Maximize Cell Therapy Dose Manufacture and Substantially Reduce Donor Hemoglobin Loss." BMC Medicine 21, no. 1 (2023): 1. https://doi.org/10.1186/s12916-023-03059-3.
MLA (9th ed.) CitationEpah, Jeremy, et al. "Small Volume Bone Marrow Aspirates with High Progenitor Cell Concentrations Maximize Cell Therapy Dose Manufacture and Substantially Reduce Donor Hemoglobin Loss." BMC Medicine, vol. 21, no. 1, 2023, p. 1, https://doi.org/10.1186/s12916-023-03059-3.